News

Gladstone in the News October 7, 2021

Meet the Most Influential Women in Bay Area Business, Class of 2021

San Francisco Business Times—Senior Investigator Katerina Akassoglou, PhD, was picked by the San Francisco Business Times as one of the most influential women in business in the Bay Area this year.

Gladstone Experts Center for Neurovascular Brain Immunology Akassoglou Lab Diversity

Article August 24, 2021

Overcoming Obstacles to Promote Repair in Multiple Sclerosis

Study points to a new promising therapy against toxic blood leaks in the brain

News Release Research (Publication) Alzheimer’s Disease Center for Neurovascular Brain Immunology Neurological Disease Akassoglou Lab

Article March 26, 2021

Leading the Way to Better Treatments for People with Epilepsy

Gladstone researchers harness unique tools and perspectives to study life-threatening seizures that lack a cure

Gladstone Experts Epilepsy Neurological Disease Center for Neurovascular Brain Immunology Akassoglou Lab Mucke Lab Palop Lab Paz Lab Deep Dive

Article February 16, 2021

Blood-Clotting Protein Plays Key Role in Central Nervous System B-Cell Lymphoma

Gladstone researchers discover new links between lymphoma growth and leaks in the blood-brain barrier

News Release Research (Publication) Center for Neurovascular Brain Immunology Neurological Disease Akassoglou Lab

Article January 28, 2021

New Research Center to Tackle Brain Diseases

A unique combination of expertise at Gladstone Institutes and UC San Francisco will enable new therapies for Alzheimer’s disease and multiple sclerosis

Institutional News News Release Multiple Sclerosis Alzheimer’s Disease Akassoglou Lab

Article January 28, 2021

The Simon Family Trust Donates $2.5 Million to Biomedical Science

The philanthropic gift will support cross-disciplinary research to find novel treatments for multiple neurological diseases

Donor Stories Multiple Sclerosis Alzheimer’s Disease Akassoglou Lab

Article December 14, 2020

An Unexpected Role for the Brain’s Immune Cells

The cells constantly survey the brain to prevent spontaneous seizures, Gladstone scientists discover

News Release Research (Publication) Multiple Sclerosis Alzheimer’s Disease Neurological Disease Akassoglou Lab Palop Lab Imaging

Article October 14, 2020

Young Scientists Committed to Finding Treatments for Neurodegenerative Diseases

The 2020 Berkelhammer Scholars break new ground in research on dementias, Parkinson’s disease, and neuropsychiatric disorders

Donor Stories Parkinson’s Disease Alzheimer’s Disease Dementia Neurological Disease Akassoglou Lab Kreitzer Lab Mahley Lab Mucke Lab Nakamura Lab

Gladstone in the News October 2, 2020

Next Wave of Bay Area Neuroscience Companies: What Are They Doing Now?

San Francisco Business Times—Gabaeron, founded by Gladstone President Emeritus Bob Mahley, MD, PhD, and Therini Bio (formerly Medared), founded upon work by Senior Investigator Katarina Akassoglou, PhD, are among Bay Area biotech companies focusing on neurological diseases that collectively raised more than $3 billion from venture capital firms and the public capital markets in 2020.

Gladstone Experts Parkinson’s Disease Multiple Sclerosis Alzheimer’s Disease Neurological Disease Akassoglou Lab Mahley Lab

Gladstone in the News July 20, 2020

Revealing the Genetic Signature of Neurodegenerative Disease

Drug Target Review—Senior Investigator Katerina Akassoglou, PhD, explains her team’s recent discovery of the immune cells in the brain that promote neurodegeneration in diseases such as multiple sclerosis and Alzheimer’s disease.

Gladstone Experts Multiple Sclerosis Alzheimer’s Disease Neurological Disease Akassoglou Lab

Gladstone in the News June 10, 2020

Researchers Profile Immune Cells Implicated in Neurodegenerative Disease

ImmunoFrontiers—Senior Investigator Katerina Akassoglou, PhD, describes her lab's recent discovery of the genetic mechanisms that drive brain inflammation in neurodegenerative diseases.

Gladstone Experts Parkinson’s Disease Multiple Sclerosis Alzheimer’s Disease Neurological Disease Akassoglou Lab

Article April 24, 2020

From HIV to COVID-19

Researchers who spent decades studying human immunodeficiency virus are using some of the same tools and approaches to tackle SARS-CoV-2, the virus that causes COVID-19.

Gladstone Experts COVID-19 HIV/AIDS Center for HIV Cure Research Infectious Disease Akassoglou Lab Doudna Lab Greene Lab Ott Lab

Article April 13, 2020

Toxic Cell Atlas Guides New Therapies for Neurodegeneration

New study generates an “atlas” of toxic immune cells in the brain.

News Release Research (Publication) Assay Development and Drug Discovery Core Neurological Disease Akassoglou Lab

Article October 29, 2019

$4.5 Million to Study How Neurovascular Dysfunction Contributes to Neurodegeneration in Alzheimer’s Disease

Jorge Palop and Katerina Akassoglou received an NIH grant to study the link between neurovascular dysfunction and cognitive decline in Alzheimer’s disease.

News Release Research (Publication) Alzheimer’s Disease Neurological Disease Akassoglou Lab Palop Lab

Article October 8, 2019

New Bay Area Spin-Off Company to Develop Drugs for Multiple Sclerosis and Alzheimer’s Disease

Senior Investigator Katerina Akassoglou has fundamentally changed the way scientists think of neurological disorders. She made the seminal discovery that blood leaks are toxic to the brain by promoting inflammation and destroying neurons. Her research led the scientific community to reassess the complex relationship between the brain, immune, and vascular systems.

Business Development Institutional News Assay Development and Drug Discovery Core Alzheimer’s Disease Multiple Sclerosis Neurological Disease Akassoglou Lab